First Diagnostic Corporation, founded in 2004, brands and distributes lateral flow rapid tests for professional use under the ATFirst™ and inSTIcheck™ names.
We select rapid tests from established in vitro diagnostic (IVD) manufacturers, supply them under our own brands and support the distributors who take them to market. The range is built around lateral flow tests: single-use cassettes that give a visual, qualitative result in minutes without an instrument.
General rapid tests: hepatitis B and C, HIV combination tests, malaria, dengue, influenza, rubella, cardiac markers and more.
Rapid tests for sexually transmitted infections: chlamydia and gonorrhea antigen tests and a syphilis antibody test.
The name under which our HBsAg test was first marketed. The product is supplied today as ATFirst™ HBsAg.
First Diagnostic does not manufacture tests. Each product is made by an IVD manufacturer and labeled for First Diagnostic. The instructions for use packed with the kit are the reference for the intended use, the specimen, the procedure, the read time, the storage conditions and the performance data.
Each product page states its source. Where a published insert reports sensitivity and specificity against a comparator method and the figures agree with its data table, we publish them with the sample counts. Where no insert is published, the page gives catalog facts only and no performance claims. Details are on the quality and regulatory page.
Our products are intended for organizations that use or distribute tests professionally: medical distributors and importers, public health programs, hospitals, clinical laboratories and clinics. We supply buyers outside the United States; our products are not cleared, approved or authorized by the U.S. Food and Drug Administration and are not offered for sale there.
Two longer-term goals sit alongside the current range: digital reading of lateral flow results through a cassette reader, and rapid detection of tumor-associated markers, a research area we follow in the resource center. Both are goals, not products, and we will describe each as available only when it is.
Medical and technical content on this site is written for healthcare and procurement professionals. Product facts come from the product insert or, where no insert is published, from our catalog. Guides in the resource center cite the public health and regulatory sources they rely on. Each page shows when it was last reviewed.
If you find an error, email sales@firstdiagnostic.com and we will correct it.
Distributors can apply for qualification online. Manufacturers and buyers can reach the sales desk by email.
Regulatory status: Products shown on this website are for professional in vitro diagnostic use. They are not cleared, approved or authorized by the U.S. Food and Drug Administration and are not offered for sale in the United States. Product availability and regulatory status vary by country; contact us for the status in your market.